vs

Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $38.9M, roughly 1.9× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 8.7%, a 16.0% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 10.6%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 6.2%).

Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

BFS vs CDXS — Head-to-Head

Bigger by revenue
BFS
BFS
1.9× larger
BFS
$75.1M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+70.7% gap
CDXS
81.3%
10.6%
BFS
Higher net margin
CDXS
CDXS
16.0% more per $
CDXS
24.7%
8.7%
BFS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
6.2%
BFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFS
BFS
CDXS
CDXS
Revenue
$75.1M
$38.9M
Net Profit
$6.5M
$9.6M
Gross Margin
94.8%
Operating Margin
65.4%
27.1%
Net Margin
8.7%
24.7%
Revenue YoY
10.6%
81.3%
Net Profit YoY
-19.6%
192.5%
EPS (diluted)
$0.15
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFS
BFS
CDXS
CDXS
Q4 25
$75.1M
$38.9M
Q3 25
$72.0M
$8.6M
Q2 25
$70.8M
$15.3M
Q1 25
$71.9M
$7.5M
Q4 24
$67.9M
$21.5M
Q3 24
$67.3M
$12.8M
Q2 24
$66.9M
$8.0M
Q1 24
$66.7M
$17.1M
Net Profit
BFS
BFS
CDXS
CDXS
Q4 25
$6.5M
$9.6M
Q3 25
$10.5M
$-19.6M
Q2 25
$10.7M
$-13.3M
Q1 25
$9.8M
$-20.7M
Q4 24
$8.1M
$-10.4M
Q3 24
$14.5M
$-20.6M
Q2 24
$14.4M
$-22.8M
Q1 24
$13.6M
$-11.5M
Gross Margin
BFS
BFS
CDXS
CDXS
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
73.6%
66.4%
Q2 24
74.2%
56.6%
Q1 24
72.8%
71.6%
Operating Margin
BFS
BFS
CDXS
CDXS
Q4 25
65.4%
27.1%
Q3 25
69.1%
-220.3%
Q2 25
68.7%
-83.9%
Q1 25
66.5%
-271.6%
Q4 24
82.9%
-34.2%
Q3 24
72.8%
-129.0%
Q2 24
75.0%
-284.9%
Q1 24
72.4%
-69.6%
Net Margin
BFS
BFS
CDXS
CDXS
Q4 25
8.7%
24.7%
Q3 25
14.6%
-228.1%
Q2 25
15.1%
-86.6%
Q1 25
13.6%
-274.3%
Q4 24
11.9%
-48.4%
Q3 24
21.5%
-160.8%
Q2 24
21.6%
-285.2%
Q1 24
20.4%
-67.4%
EPS (diluted)
BFS
BFS
CDXS
CDXS
Q4 25
$0.15
$0.13
Q3 25
$0.32
$-0.22
Q2 25
$0.33
$-0.16
Q1 25
$0.29
$-0.25
Q4 24
$0.22
$-0.12
Q3 24
$0.48
$-0.29
Q2 24
$0.48
$-0.32
Q1 24
$0.45
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFS
BFS
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$8.7M
$78.2M
Total DebtLower is stronger
$468.4M
$40.1M
Stockholders' EquityBook value
$307.8M
$50.5M
Total Assets
$2.2B
$147.8M
Debt / EquityLower = less leverage
1.52×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFS
BFS
CDXS
CDXS
Q4 25
$8.7M
$78.2M
Q3 25
$11.8M
$58.7M
Q2 25
$5.3M
$66.3M
Q1 25
$6.5M
$59.8M
Q4 24
$10.3M
$73.5M
Q3 24
$7.2M
$90.3M
Q2 24
$6.9M
$73.2M
Q1 24
$7.1M
$85.5M
Total Debt
BFS
BFS
CDXS
CDXS
Q4 25
$468.4M
$40.1M
Q3 25
$1.6B
$39.7M
Q2 25
$1.6B
$39.4M
Q1 25
$1.5B
$29.2M
Q4 24
$455.8M
$28.9M
Q3 24
$1.5B
$28.6M
Q2 24
$1.4B
$28.4M
Q1 24
$1.4B
$28.1M
Stockholders' Equity
BFS
BFS
CDXS
CDXS
Q4 25
$307.8M
$50.5M
Q3 25
$316.6M
$38.5M
Q2 25
$322.4M
$55.6M
Q1 25
$328.4M
$49.6M
Q4 24
$335.8M
$66.9M
Q3 24
$341.8M
$73.4M
Q2 24
$345.7M
$61.4M
Q1 24
$347.1M
$79.3M
Total Assets
BFS
BFS
CDXS
CDXS
Q4 25
$2.2B
$147.8M
Q3 25
$2.2B
$124.0M
Q2 25
$2.1B
$138.2M
Q1 25
$2.1B
$128.9M
Q4 24
$2.1B
$149.0M
Q3 24
$2.1B
$148.2M
Q2 24
$2.1B
$132.0M
Q1 24
$2.0B
$149.6M
Debt / Equity
BFS
BFS
CDXS
CDXS
Q4 25
1.52×
0.79×
Q3 25
5.02×
1.03×
Q2 25
4.85×
0.71×
Q1 25
4.70×
0.59×
Q4 24
1.36×
0.43×
Q3 24
4.37×
0.39×
Q2 24
4.17×
0.46×
Q1 24
4.06×
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFS
BFS
CDXS
CDXS
Operating Cash FlowLast quarter
$99.8M
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
15.35×
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFS
BFS
CDXS
CDXS
Q4 25
$99.8M
$20.1M
Q3 25
$20.6M
$-7.7M
Q2 25
$26.6M
$-18.0M
Q1 25
$30.4M
$-13.8M
Q4 24
$121.2M
$-16.5M
Q3 24
$26.5M
$-13.0M
Q2 24
$32.1M
$-12.2M
Q1 24
$33.8M
$-7.8M
Free Cash Flow
BFS
BFS
CDXS
CDXS
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-28.3M
$-14.0M
Q2 24
$-12.5M
$-12.6M
Q1 24
$-11.7M
$-8.9M
FCF Margin
BFS
BFS
CDXS
CDXS
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-42.1%
-109.0%
Q2 24
-18.7%
-157.5%
Q1 24
-17.6%
-52.2%
Capex Intensity
BFS
BFS
CDXS
CDXS
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
81.5%
7.8%
Q2 24
66.7%
5.0%
Q1 24
68.3%
6.6%
Cash Conversion
BFS
BFS
CDXS
CDXS
Q4 25
15.35×
2.09×
Q3 25
1.97×
Q2 25
2.48×
Q1 25
3.10×
Q4 24
14.98×
Q3 24
1.83×
Q2 24
2.22×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons